A statement from Gary M. Reedy, CEO of the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) on the death of civil rights champion and U.S. Congressman Rep. John Lewis from pancreatic cancer.
Remove Hurdles to Cancer Care Press Releases
The Department of Health and Human Services (HHS) this week finalized the 2021 Notice of Benefit and Payment Parameters, which sets the rules for health care plans in the coming year.
The administration released its FY21 budget today which contains significant cuts to health care programs. If implemented, the cuts could leave millions more Americans uninsured and unable to access comprehensive health coverage and stall medical research essential to preventing, detecting and treating cancer.
Improving Access to Health Care in Illinois Tops American Cancer Society Cancer Action Network’s List of 2020 Legislative Priorities
SPRINGFIELD, Ill. – January 21, 2020 – As lawmakers dive into the new year, the American Cancer Society Cancer Action Network (ACS CAN) is pursuing legislation that will ease the burden of cancer in Illinois.
Congress is poised to pass a funding bill this week that includes a $2.6 billion increase for medical research at the National Institutes of Health (NIH). The measure, agreed upon by both House and Senate conference committee members, also provides $296 million increase for the National Cancer Institute (NCI).
House to Vote on Comprehensive Drug Pricing Legislation, Provisions Include Capping Medicare Patients’ Out-of-Pocket Prescription Drug Costs
The U.S. House will vote today on a bill intended to bring down patient prescription drug costs. Several of the bill’s provisions are important to cancer care, including establishing an annual cap on Medicare enrollees’ out-of-pocket expenses, allowing some Medicare beneficiaries to spread out high-cost prescription cost-sharing over the course of the year, and expanding Medicare eligibility for low-income subsidies.
Senate Finance Committee Proposes Capping Medicare Patients’ Out-of-Pocket Prescription Drug Costs in Drug Pricing Bill
Today the Senate Finance Committee is marking up the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, which includes a provision to cap Medicare beneficiaries’ out-of-pocket prescription drug costs in Medicare Part D, among several other proposed changes intended to bring down patient costs.
Today the House Energy and Commerce Subcommittee on Health will mark-up a series of bills aimed at reducing patient out-of-pocket costs and preserving access to health care. Specifically, the committee will consider a measure that would exempt patients from having to pay surprise medical bills in most circumstances.